Font Size:
a
A
A
Keyword [CTLA-4]
Result: 181 - 200 | Page: 10 of 10
181.
Expression And Purification Of The Recombinant Human CTLA-4 Extracellular Domain And Screening And Functional Identification Of Its Nanobody
182.
Research On The Mechanism Of Cytokine IL-33 Combined With Immune Checkpoint Molecules Monoclonal Antibody In Antitumor Immune Response
183.
Enhancing T cell immunity in tumor immunotherapy
184.
Immunogenetic and environmental risk factors for scleroderma and lupus
185.
T cell costimulation in anti-tumor immunity and autoimmunity
186.
Effects of modified CD80 on the co-stimulation of T cell
187.
AT-repeat polymorphisms of the human CTLA-4 gene: Associations with autoimmune diabetes and allele-specific variation of expression
188.
Polymorphic variants of human Fc-gamma-RIIIa, gamma-chain, CTLA-4 and Fc-gamma-RIIb1: Possible implications for systemic lupus erythematosus pathogenesis
189.
Signaling through CD28 family receptors: An analysis of CD80- and CD86-dependent pathways
190.
Cell-extrinsic and intrinsic regulation of N-glycosylation in health and disease
191.
Association Between Polymorphisms Of CTLA-4?IL-10 Gene And Breast Cancer In Chinese Han Population
192.
Experimental Study Of Novel PMMA Bone Cement Loaded With TLR-7 Agonist Combined With Anti-CTLA-4 Antibody For Cancer Therapy
193.
The Value Of Cytokines Expression Of Th1/Th2/Th17 And The Urinary CD80 Excretion In Adult-onset Minimal Change Disease
194.
Relationship Between T Cell Exhaustion Mediated By Negative Co-Stimulatory Molecule In Severe Hand,Foot,and Mouth Disease
195.
Breast Cancer Cells Promote Tumor Development And Immune Escape Through The Expression Of Inhibitory Molecule CTLA-4 And IL-35
196.
Meta-analysis Of The Efficacy And Safety Of Immune Checkpoint Inhibitors Combined With Hypomethylating Agents In The Treatment Of Acute Myeloid Leukemia And Myelodysplastic Syndromes
197.
A Preliminary Study On The Relationship And Mechanism Of CTLA-4 In The Pathogenesis Of AIDS In Chinese Rhesus Monkeys
198.
Meta Analysis Of Efficacy And Safety Of PD-1/PD-L1 Or CTLA-4 Inhibitors Combined With Chemotherapy In The Treatment Of Non-small Cell Lung Cancer
199.
Establishment,Optimization And Validation Of Ipilimumab Assay In Vitro
200.
Significance Of Soluble PD-L1,CTLA-4 And B7-H3 In Peripheral Blood In Healthy Patients And Patients With Lung Cancer Treated With PD-1 Inhibitors
<<First
<Prev
Next>
Last>>
Jump to